SHSodai Hoshiai

Sodai Hoshiai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sodai Hoshiai has a total of 73 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Balloon-occluded Infusion of Fragmented Gelatin Particles of Transarterial Embolization for Hypervascular Hepatic Metastases: A Prospective Trial

    by Sodai Hoshiai, Takeshi Yamada, Mariko Kobayashi, Taishi Amano, Nobuyuki Takahashi, Bryan J. Mathis, Tsukasa Saida, Takahito Nakajima, Toshiyuki Irie

    Balloon-occluded infusion of fragmented gelatin particles of transarterial embolization (BOIG-TAE) is a chemotherapy-free technique combining selective balloon occlusion with gelatin particle embolization. This prospective, single-arm study (June 2022-June 2025) enrolled patients with hypervascular hepatic metastases refractory or intolerant to standard systemic therapy, with safety as the primary endpoint and preliminary efficacy and hepatic function as secondary endpoints. Adverse events were evaluated using Society of Interventional Radiology (SIR) criteria. Tumor response was independently assessed two months after treatment using modified Response Evaluation Criteria in Solid Tumors (mRECIST) and hepatic function was monitored using Child-Pugh and albumin-bilirubin (ALBI) scores. Six patients were enrolled (median age, 77 years; 4 male patients). One patient experienced transient abdominal pain lasting one week (SIR grade C); no other major complications occurred. Transient elevations in aspartate aminotransferase and alanine aminotransferase occurred in all patients and resolved within one month. No biliary or renal complications were recorded. The objective response rate at two months was 66.7% (4/6) and Child-Pugh and ALBI scores remained stable during follow-up. BOIG-TAE may be feasible and generally well tolerated in selected patients, with potential for short-term tumor control while preserving hepatic function.

  • Open Access

    Comparison of MR Imaging of High-grade Serous Carcinomas with and without Homologous Recombination-deficiency

    by Tsukasa Saida, Ayumi Shikama, Miki Yoshida, Taishi Amano, Toshitaka Ishiguro, Masafumi Sakai, Sodai Hoshiai, Toyomi Satoh, Takahito Nakajima

    Purpose: MRI findings of high-grade serous carcinoma (HGSC) with and without homologous recombinationdeficiency (HRD) were compared to explore the feasibility of using MRI as a genetic predictor. Methods: We retrospectively reviewed MRI data from HRD-positive and HRD-negative HGSC andevaluated tumor size, appearance, apparent diffusion coefficient (ADC), time-intensity curve, and severaldynamic contrast-enhanced curve descriptors. Age, primary site, tumor stage, bilaterality, presence oflymph node metastasis, presence of peritoneal metastasis, and tumor marker levels were also compared. Results: Forty-eight patients with HRD-positive HGSC (17 patients with BRCA1 variant, 9 patients withBRCA2 variant, and 22 without BRCA variants) and 18 patients with HRD-negative HGSC were included.The HRD-negative patients’ mean age was 67 years, which was significantly higher than that of the HRDpositivepatients (60 years, P = 0.011). High-risk time-intensity curve (TIC) patterns were more common inHRD-negative tumors (94%) than in HRD-positive tumors (63%; P = 0.047). Tumors without HRDexhibited significantly higher wash-in rates (P = 0.023). Additionally, unresectable lymph node metastaseswere significantly more frequent in HRD-negative patients (P = 0.013). No significant differences wereobserved in the other evaluated factors. Conclusion: The comparison between HGSC with and without HRD revealed that HGSC without HRD was significantly associated with older age, a higher likelihood of exhibiting a high-risk TIC pattern, ahigher wash-in rate, and a higher frequency of unresectable lymph node metastasis.


  • Prognostic imaging features of ovarian clear cell carcinoma on multiparametric MRI

    by Tetsuya Abe, Tsukasa Saida, Miki Yoshida, Kaoru Fujieda, Sodai Hoshiai, Toshitaka Ishiguro, Taishi Amano, Ayumi Shikama, Toyomi Satoh, Takahito Nakajima

    Objective To compare preoperative MRI features between ovarian clear cell carcinoma (CCC) patients with favorable versus unfavorable clinical outcomes and to identify imaging predictors associated with adverse outcomes. Methods We retrospectively analyzed patients with pathologically confirmed CCC to compare preoperative MRI and clinical features between the recurrence-free and unfavorable-outcome groups. Quantitative variables included MRI parameters such as tumor size, T1 ratio of the cystic component, and for the solid component, maximum width and height, T2 ratio, apparent diffusion coefficient (ADC), and dynamic contrast-enhanced (DCE) metrics, as well as clinical/laboratory data (age and serum tumor marker levels). Qualitative variables included MRI findings such as number of locules, number of solid components (≤ 3 vs. ≥4 solid components or diffuse mural thickening), presence of marked T2 hyperintensity, growth pattern, presence of necrosis, and time–intensity curve (TIC) pattern, as well as FIGO stage, and surgical completeness. Results Seventy-two patients were included (recurrence-free, n = 45; unfavorable-outcome, n = 27). The distribution of FIGO stage differed between the groups (p < 0.001), and complete surgery was achieved significantly less often in the unfavorable-outcome group (77.8%, p = 0.002). Among the MRI parameters, only ≥ 4 solid components were significantly associated with unfavorable outcomes (p = 0.020). In stage I–II cases, the same trend was observed, although not significant (p = 0.147). No significant associations were observed for any other variables, including tumor size, T1 ratio of the cystic component, maximum width and height of the solid component, growth pattern, T2 ratio, ADC, DCE metrics, TIC pattern, or clinical and laboratory data (p = 0.050–1.000). Conclusion In this cohort of CCC patients, multiparametric MRI showed that the presence of four or more solid components, together with FIGO stage and surgical completeness, was associated with unfavorable clinical outcomes, suggesting a potential role for MRI-based risk stratification that warrants external validation. Graphical abstract

  • Open Access

    Multicenter, prospective clinical trial for balloon-occluded alternative infusion of cisplatin solution and fragmented gelatin particles of transarterial chemoembolization for hepatocellular carcinoma beyond up-to-seven criteria

    by Sodai Hoshiai, Naoyuki Hasegawa, Takeshi Yamada, Nobuyuki Takahashi, Kensaku Mori, Kouichi Mori, Kuniaki Fukuda, Daichi Takizawa, Bryan J. Mathis, Takahito Nakajima, et al.

    Transarterial chemoembolization (TACE) is considered unsuitable for hepatocellular carcinoma (HCC) that exceeds up-to-7 criteria. Balloon-occluded alternative infusion of cisplatin solution and gelatin particles of transarterial chemoembolization (BOAI-TACE) has shown promise in the treatment of HCC and preservation of liver function. This prospective, single-arm study enrolled patients with HCC beyond up-to-7 criteria from five hospitals. The primary endpoint was objective response ratio (ORR) for BOAI-TACE, according to response evaluation criteria in cancer of the Liver (RECICL), at 2 months after treatment. Eighteen patients were enrolled in this study. Fourteen patients achieved response, resulting in an ORR of 77.8% (95% confidence interval [CI] 54.3–91.5%) according to both RECICL and modified response evaluation criteria in solid tumor (mRECIST) guidelines, meeting the primary endpoint. Disease control rate was 88.9% (95% CI 66.0–98.1%). No worsening of either Child–Pugh or albumin–bilirubin (ALBI) scores was observed. No serious adverse events were recorded, indicating that BOAI-TACE retains utility even in severe HCC cases while preserving liver function.


  • Open Access

    Artificial Intelligence in Obstetric and Gynecological MR Imaging

    by Tsukasa Saida, Wenchao Gu, Sodai Hoshiai, Toshitaka Ishiguro, Masafumi Sakai, Taishi Amano, Yuta Nakahashi, Ayumi Shikama, Toyomi Satoh, Takahito Nakajima

    This review explores the significant progress and applications of artificial intelligence (AI) in obstetrics and gynecological MRI, charting its development from foundational algorithmic techniques to deep learning strategies and advanced radiomics. This review features research published over the last few years that has used AI with MRI to identify specific conditions such as uterine leiomyosarcoma, endometrial cancer, cervical cancer, ovarian tumors, and placenta accreta. In addition, it covers studies on the application of AI for segmentation and quality improvement in obstetrics and gynecology MRI. The review also outlines the existing challenges and envisions future directions for AI research in this domain. The growing accessibility of extensive datasets across various institutions and the application of multiparametric MRI are significantly enhancing the accuracy and adaptability of AI. This progress has the potential to enable more accurate and efficient diagnosis, offering opportunities for personalized medicine in the field of obstetrics and gynecology.


  • Open Access

    Comparison of Benign, Borderline, and Malignant Ovarian Seromucinous Neoplasms on MR Imaging

    by Tsukasa Saida, Miki Yoshida, Toshitaka Ishiguro, Sodai Hoshiai, Masafumi Sakai, Taishi Amano, Saki Shibuki, Toyomi Satoh, Takahito Nakajima

    Purpose: This study aimed to compare MRI findings among benign, borderline, and malignant ovarian seromucinous neoplasms.Methods: We retrospectively analyzed MRI data from 24 patients with ovarian seromucinous neoplasms—seven benign, thirteen borderline, and six malignant. The parameters evaluated included age, tumour size, morphology, number, height, apparent diffusion coefficient (ADC) values, T2 ratios, time-intensity curve (TIC) descriptors, and TIC patterns of the mural nodules. Additionally, we examined the T2 and T1 ratios of the cyst contents, tumour markers, and the presence of endometriosis. We used statistical tests, including the Kruskal–Wallis and Fisher–Freeman–Halton exact tests, to compare these parameters among the three aforementioned groups.Results: The cases showed papillary architecture with internal branching in 57% of benign, 92% of borderline, and 17% of malignant cases. Three or fewer mural nodules were seen in 57% of benign, 8% of borderline, and 17% of malignant cases. Compared to benign and borderline tumours, mural nodules of malignant neoplasms had significantly increased height (P = 0.015 and 0.011, respectively), lower means ADC values (P = 0.003 and 0.035, respectively). The mural nodules in malignant cases also demonstrated significantly lower T2 ratios than those in the benign cases (P = 0.045). Most neoplasms displayed an intermediate-risk TIC pattern, including 80% benign, 83% borderline, and 60% malignant neoplasms, and no significant differences were observed.Conclusion: Most benign and borderline tumours exhibited a papillary architecture with an internal branching pattern, whereas this feature was less common in malignant neoplasms. Additionally, benign tumours had fewer mural nodules compared to borderline tumours. Malignant neoplasms were characterized by mural nodules with increased height and lower ADC values than those in benign and borderline tumours. Interestingly, all three groups predominantly exhibited an intermediate-risk TIC pattern, emphasizing the complexity of diagnosing seromucinous neoplasms using MRI.


  • Imaging of unicentric hyaline-vascular variant of Castleman disease: Emphasis on perilesional fat stranding and fatty proliferation

    by Sodai Hoshiai, Takeyuki Watadani, Shun Kagaya, Taishi Amano, Tomohiko Masumoto, Haruyasu Yamada, Izuru Matsuda, Ryota Matsuoka, Tetsuo Ushiku, Takahito Nakajima, et al.

    The hyaline-vascular variant of Castleman disease (HVCD) is relatively uncommon and demonstrates no specific clinical or laboratory findings; therefore, its preoperative diagnosis warrants a radiological evaluation. This study aimed to review imaging findings of HVCD, focusing on perilesional fat stranding and fatty proliferation. Patients with a pathologically confirmed HVCD diagnosis who had undergone CT were recruited from five hospitals from January 2000 to March 2023. Three experienced radiologists assessed CT findings, including lesion location, lesion size, calcification, enhanced pattern, feeding vessel visualization, and arterial enhancement. Perilesional fat stranding, fatty proliferation, neighboring fascial thickening, and surrounding lymphadenopathy were the primary targets of analysis. Moreover, the intensities and apparent diffusion coefficient (ADC) values on MRI and the maximum standardized uptake value (SUVmax) on 18F-fluorodeoxyglucose positron emission tomography (PET) were evaluated. This study enrolled 43 patients (mean age 41.3 years ± 14.6 [standard deviation], 23 women). All lesions were well-defined round masses. Calcification and feeding vessels were detected in 21% (9/43) and 86% (36/43) of the patients, respectively. Perilesional fat stranding and fatty proliferation were observed in 44% (19/43) and 19% (8/43), respectively, with fatty proliferation detected only in retroperitoneal HVCD. Neighboring fascial thickening and surrounding lymphadenopathy were identified in 21% and 60%, respectively. The mean ADC value and SUVmax were 0.884 × 10−3 mm2/s and 5.0, respectively. Retroperitoneal HVCD cases with perilesional fatty proliferation demonstrated a higher visceral fat ratio than those without (p = 0.046). Perilesional fat stranding and fatty proliferation were new characteristics of HVCD, especially in retroperitoneal cases.


  • Open Access

    Comparison of preoperative diagnostic performance between dual-energy CT, conventional CT, and MRI in endometrial cancer

    by Miki Yoshida, Tsukasa Saida, Kensaku Mori, Sodai Hoshiai, Masafumi Sakai, Taishi Amano, Saki Shibuki, Mariko Miyata, Toyomi Sato, Takahito Nakajima

    Purpose: To compare the diagnostic performance of virtual monoenergetic imaging (VMI), computed tomography (CT), and magnetic resonance imaging (MRI) in patients with endometrial cancer (EC).Material and methods: This retrospective study analysed 45 EC patients (mean age: 62 years, range: 44–84 years) undergoing contrast-enhanced CT with dual-energy CT (DECT) and MRI between September 2021 and October 2022. Dual-energy CT generated conventional CT (C-CT) and 40 keV VMI. Quantitative analysis compared contrast-to-noise ratio (CNR) of tumour to myometrium between C-CT and VMI. Qualitative assessment by 5 radiologists compared C-CT, VMI, and MRI for myometrial invasion (MI), cervical invasion, and lymph node metastasis. Sensitivity, specificity, accuracy, and area under the receiver operating characteristic curve (AUC) were calculated and compared for each diagnostic parameter.Results: Virtual monoenergetic imaging showed significantly higher CNR than C-CT (p < 0.001) and a higher sensitivity for MI than C-CT (p = 0.027) and MRI (p = 0.011) but lower specificity than MRI (p = 0.018). C-CT had a higher sensitivity and AUC for cervical invasion than MRI (p = 0.018 and 0.004, respectively).Conclusions: The study found no significant superiority of MRI over CT across all diagnostic parameters. VMI demonstrated heightened sensitivity for MI, and C-CT showed greater sensitivity and AUC for cervical invasion than MRI. This suggests that combining VMI with C-CT holds promise as a comprehensive preoperative staging tool for EC when MRI cannot be performed.


  • Open Access

    Imaging findings in inflammatory disease of the genital organs

    by Saki Shibuki, Tsukasa Saida, Sodai Hoshiai, Toshitaka Ishiguro, Masafumi Sakai, Taishi Amano, Tetsuya Abe, Miki Yoshida, Kensaku Mori, Takahito Nakajima

    This review focuses on inflammatory diseases of female and male genital organs and discusses their epidemiology, pathogenesis, clinical presentation, and imaging findings. The female section covers pelvic inflammatory disease (PID) primarily caused by sexually transmitted infections (STIs) that affect the uterus, fallopian tubes, and ovaries. Unusual causes such as actinomycosis and tuberculosis have also been explored. The male section delves into infections affecting the vas deferens, epididymis, testes, prostate, and seminal vesicles. Uncommon causes such as tuberculosis, and Zinner syndrome have also been discussed. In addition, this review highlights other conditions that mimic male genital tract infections such as vasculitis, IgG4-related diseases, and sarcoidosis. Accurate diagnosis and appropriate management of these inflammatory diseases are essential for preventing serious complications and infertility. Imaging modalities such as ultrasound, magnetic resonance imaging, and computed tomography play a crucial role in diagnosis. Understanding the diverse etiologies and imaging findings is vital for the effective management of inflammatory diseases of the genital organs.


  • Effectiveness of temporal subtraction computed tomography images using deep learning in detecting vertebral bone metastases

    by Sodai Hoshiai, Shouhei Hanaoka, Tomohiko Masumoto, Yukihiro Nomura, Kensaku Mori, Yoshikazu Okamoto, Tsukasa Saida, Toshitaka Ishiguro, Masafumi Sakai, Takahito Nakajima